Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q40443765
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010713.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q40443765
|
024
|
|
|
‡a
0000-0002-8365-1380
‡2
orcid
|
024
|
|
|
‡a
8257325600
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q40443765
|
100
|
0 |
|
‡a
Miguel Melo
‡9
ast
‡9
es
‡9
sl
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Miguel Melo
‡c
researcher (ORCID 0000-0002-8365-1380)
‡9
en
|
400
|
0 |
|
‡a
Miguel Melo
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?
|
670
|
|
|
‡a
Author's ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
|
670
|
|
|
‡a
Author's Introduction
|
670
|
|
|
‡a
Author's Laparoscopic adrenalectomy as an effective approach to massive bilateral pheochromocytomas
|
670
|
|
|
‡a
Author's Long-term survival in a patient with brain metastases of papillary thyroid carcinoma
|
670
|
|
|
‡a
Author's NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
|
670
|
|
|
‡a
Author's Other Rare Tumours and Tumour-Like Lesions
|
670
|
|
|
‡a
Author's Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1
|
670
|
|
|
‡a
Author's pmTOR is a marker of aggressiveness in papillary thyroid carcinomas
|
670
|
|
|
‡a
Author's Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease
|
670
|
|
|
‡a
Author's Prevalence of Dental Caries in Type 1 Diabetic Patients Treated with Insulin Pump
|
670
|
|
|
‡a
Author's Prevalência de Lesões de Cárie de Doentes com Diabetes Mellitus Tipo 1 Tratados com Múltiplas Administrações de Insulina e de Indivíduos sem Diabetes
|
670
|
|
|
‡a
Author's Prognostic biomarkers in thyroid cancer
|
670
|
|
|
‡a
Author's Rare Familial Tumours
|
670
|
|
|
‡a
Author's Rare Follicular Tumours
|
670
|
|
|
‡a
Author's Rare Papillary Thyroid Carcinomas
|
670
|
|
|
‡a
Author's Selenium and Thyroid Disease: From Pathophysiology to Treatment
|
670
|
|
|
‡a
Author's Small Cell Tumours
|
670
|
|
|
‡a
Author's Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later
|
670
|
|
|
‡a
Author's Telomerase promoter mutations in cancer: an emerging molecular biomarker?
|
670
|
|
|
‡a
Author's TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
|
670
|
|
|
‡a
Author's TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
|
670
|
|
|
‡a
Author's The diseases we cause: Iatrogenic illness in a department of internal medicine
|
670
|
|
|
‡a
Author's The role of ablative treatment in differentiated thyroid cancer management
|
670
|
|
|
‡a
Author's Therapeutic Options
|
670
|
|
|
‡a
Author's ভূমিকা
|
909
|
|
|
‡a
(scopus) 8257325600
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000283651380
‡9
1
|
912
|
|
|
‡a
ভমক
‡A
ভূমিকা
‡9
1
|
912
|
|
|
‡a
introduction
‡A
Introduction
‡9
1
|
919
|
|
|
‡a
polymorphismsinthetnfaandil6genesrepresentriskfactorsforautoimmunethyroiddisease
‡A
Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease
‡9
1
|
919
|
|
|
‡a
prevalenceofdentalcariesintype1diabeticpatientstreatedwithinsulinpump
‡A
Prevalence of Dental Caries in Type 1 Diabetic Patients Treated with Insulin Pump
‡9
1
|
919
|
|
|
‡a
prevalenciadelesoesdecariededoentescomdiabetesmellitustipo1tratadoscommultiplasadministracoesdeinsulinaedeindividuossemdiabetes
‡A
Prevalência de Lesões de Cárie de Doentes com Diabetes Mellitus Tipo 1 Tratados com Múltiplas Administrações de Insulina e de Indivíduos sem Diabetes
‡9
1
|
919
|
|
|
‡a
prognosticbiomarkersinthyroidcancer
‡A
Prognostic biomarkers in thyroid cancer
‡9
1
|
919
|
|
|
‡a
rarefamilialtumours
‡A
Rare Familial Tumours
‡9
1
|
919
|
|
|
‡a
rarefolliculartumours
‡A
Rare Follicular Tumours
‡9
1
|
919
|
|
|
‡a
rarepapillarythyroidcarcinomas
‡A
Rare Papillary Thyroid Carcinomas
‡9
1
|
919
|
|
|
‡a
seleniumandthyroiddiseasefrompathophysiologytotreatment
‡A
Selenium and Thyroid Disease: From Pathophysiology to Treatment
‡9
1
|
919
|
|
|
‡a
smallcelltumours
‡A
Small Cell Tumours
‡9
1
|
919
|
|
|
‡a
stimulatedthyroglobulinatrecombinanthumantshaidedablationpredictsdiseasefreestatus1yearlater
‡A
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later
‡9
1
|
919
|
|
|
‡a
telomerasepromotermutationsincanceranemergingmolecularbiomarker
‡A
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
‡9
1
|
919
|
|
|
‡a
tertbrafandnrasinprimarythyroidcancerandmetastaticdisease
‡A
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
‡9
1
|
919
|
|
|
‡a
tertpromotermutationsareamajorindicatorofpooroutcomeindifferentiatedthyroidcarcinomas
‡A
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
‡9
1
|
919
|
|
|
‡a
diseaseswecauseiatrogenicillnessinadepartmentofinternalmedicine
‡A
The diseases we cause: Iatrogenic illness in a department of internal medicine
‡9
1
|
919
|
|
|
‡a
roleofablativetreatmentindifferentiatedthyroidcancermanagement
‡A
The role of ablative treatment in differentiated thyroid cancer management
‡9
1
|
919
|
|
|
‡a
therapeuticoptions
‡A
Therapeutic Options
‡9
1
|
919
|
|
|
‡a
laparoscopicadrenalectomyasaneffectiveapproachtomassivebilateralpheochromocytomas
‡A
Laparoscopic adrenalectomy as an effective approach to massive bilateral pheochromocytomas
‡9
1
|
919
|
|
|
‡a
longtermsurvivalinapatientwithbrainmetastasesofpapillarythyroidcarcinoma
‡A
Long-term survival in a patient with brain metastases of papillary thyroid carcinoma
‡9
1
|
919
|
|
|
‡a
nisexpressioninthyroidtumorsrelationwithprognosisclinicopathologicalandmolecularfeatures
‡A
NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
‡9
1
|
919
|
|
|
‡a
otherraretumoursandtumourlikelesions
‡A
Other Rare Tumours and Tumour-Like Lesions
‡9
1
|
919
|
|
|
‡a
outcomeandlongtermfollowupofadrenallesionsinmultipleendocrineneoplasiatype1
‡A
Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1
‡9
1
|
919
|
|
|
‡a
pmtorisamarkerofaggressivenessinpapillarythyroidcarcinomas
‡A
pmTOR is a marker of aggressiveness in papillary thyroid carcinomas
‡9
1
|
919
|
|
|
‡a
endocrinetumoursgeneticpredictorsofthyroidcanceroutcome
‡A
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
‡9
1
|
919
|
|
|
‡a
coexistenceoftertpromoterandbrafmutationsinpapillarythyroidcarcinomaaddedvalueinpatientprognosis
‡A
Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
ISNI|0000000037274911
|
996
|
|
|
‡2
LC|nb2019015340
|
996
|
|
|
‡2
PTBNP|1368691
|
996
|
|
|
‡2
BLBNB|000908587
|
996
|
|
|
‡2
ISNI|0000000070294551
|
996
|
|
|
‡2
ISNI|000000007081676X
|
996
|
|
|
‡2
BLBNB|001020482
|
996
|
|
|
‡2
PTBNP|1850759
|
996
|
|
|
‡2
CAOONL|ncf11688094
|
996
|
|
|
‡2
BLBNB|001423395
|
996
|
|
|
‡2
PTBNP|228983
|
996
|
|
|
‡2
SUDOC|188933441
|
996
|
|
|
‡2
PTBNP|772458
|
996
|
|
|
‡2
LC|n 85130604
|
996
|
|
|
‡2
BNCHL|10000000000000000024134
|
996
|
|
|
‡2
PTBNP|92928
|
996
|
|
|
‡2
PTBNP|92847
|
996
|
|
|
‡2
ISNI|0000000070017220
|
996
|
|
|
‡2
LC|no2010055836
|
996
|
|
|
‡2
ISNI|0000000070707264
|
996
|
|
|
‡2
PTBNP|247881
|
996
|
|
|
‡2
PTBNP|413567
|
996
|
|
|
‡2
ISNI|0000000078124530
|
996
|
|
|
‡2
ISNI|0000000385941178
|
996
|
|
|
‡2
ISNI|0000000068924745
|
996
|
|
|
‡2
PTBNP|1643797
|
996
|
|
|
‡2
PTBNP|1447576
|
996
|
|
|
‡2
ISNI|0000000070336854
|
996
|
|
|
‡2
BLBNB|001018136
|
996
|
|
|
‡2
PTBNP|228798
|
996
|
|
|
‡2
PTBNP|1742635
|
996
|
|
|
‡2
PTBNP|1318818
|
996
|
|
|
‡2
BNC|981058527224506706
|
996
|
|
|
‡2
PTBNP|1217136
|
996
|
|
|
‡2
SUDOC|059076399
|
996
|
|
|
‡2
PTBNP|1572699
|
996
|
|
|
‡2
PTBNP|132344
|
996
|
|
|
‡2
PTBNP|202631
|
996
|
|
|
‡2
ISNI|0000000428428404
|
996
|
|
|
‡2
ISNI|0000000039467848
|
996
|
|
|
‡2
ISNI|0000000069197906
|
996
|
|
|
‡2
DNB|1198365935
|
996
|
|
|
‡2
LC|no2017136970
|
996
|
|
|
‡2
ISNI|0000000419558055
|
996
|
|
|
‡2
PTBNP|69819
|
996
|
|
|
‡2
NSK|000449131
|
996
|
|
|
‡2
LC|n 89149697
|
996
|
|
|
‡2
ISNI|0000000377806574
|
996
|
|
|
‡2
ISNI|0000000068490940
|
996
|
|
|
‡2
BLBNB|000294656
|
996
|
|
|
‡2
ISNI|000000003040148X
|
996
|
|
|
‡2
PTBNP|1447831
|
996
|
|
|
‡2
ISNI|0000000069927753
|
996
|
|
|
‡2
SUDOC|143326252
|
996
|
|
|
‡2
LC|no 00089758
|
996
|
|
|
‡2
PTBNP|102484
|
996
|
|
|
‡2
ISNI|0000000030599473
|
996
|
|
|
‡2
ISNI|0000000068911725
|
996
|
|
|
‡2
NTA|353729000
|
996
|
|
|
‡2
LC|n 85368854
|
996
|
|
|
‡2
PTBNP|1813757
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|